Penumbra Inc
(STU:0P8)
€
242.6
2.7 (1.13%)
Market Cap: 9.57 Bil
Enterprise Value: 9.50 Bil
PE Ratio: 299.78
PB Ratio: 8.96
GF Score: 88/100 Penumbra Inc at Bank of America Global Healthcare Conference Transcript
May 09, 2023 / 05:40PM GMT
Release Date Price:
€288
(+2.13%)
Travis Lee Steed
BofA Securities, Research Division - MD
All right. Good morning, everybody. Travis Steed, Bank of America Medical Device analyst, kicking off the first day here. Glad to have Adam Elsesser from Penumbra, CEO.
Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO
Yes. Thanks for having.
Travis Lee Steed
BofA Securities, Research Division - MD
Yes. Thanks for joining us. Curious if you want to just open with any opening remarks or straight into Q&A?
Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO
Yes. I think we can go straight into Q&A. We're just a week off of our earnings call. So I think we've laid out where we feel we -- the business is right now pretty well.
Travis Lee Steed
BofA Securities, Research Division - MD
Yes. Yes. Sounds good.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot